Qyuns Therapeutics Co., Ltd. (02509) released a Next Day Disclosure Return dated 21 November 2025. The document indicates that on 21 November 2025, the company repurchased 49,200 H shares on the Hong Kong Stock Exchange at a price between HKD19.96 and HKD20.60, for a total payment of approximately HKD998,154.84.
Following this transaction, the number of treasury shares increased to 878,600, while the total number of issued shares remained at 227,071,600. According to the disclosed mandate, up to 22,207,160 shares are authorized for repurchase. The announcement also specifies a moratorium period through 21 December 2025 for any new share issuance or sale or transfer of treasury shares.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.